Results 11 to 20 of about 3,418,065 (230)
Medullary Thyroid Cancer: An Introduction [PDF]
Current Oncology, 2019 Medullary thyroid cancer (mtc) is a rare cancer, making up perhaps only a few percent of all thyroid cancers […
Michael Kaviraj Gupta
core +3 more sources
Cabozantinib for progressive metastatic medullary thyroid cancer: a review [PDF]
Therapeutics and Clinical Risk Management, 2014 Joshua R Colombo, Richard O Wein Department of Otolaryngology, Head and Neck Surgery, Tufts Medical Center, Boston, MA, USA Abstract: Medullary thyroid cancer is uncommon and patients typically present with advanced disease.
Colombo JR, Wein RO
doaj +1 more source
Genetic susceptibility to hereditary non-medullary thyroid cancer
Hereditary Cancer in Clinical Practice, 2022 Non-medullary thyroid cancer (NMTC) is the most common type of thyroid cancer. With the increasing incidence of NMTC in recent years, the familial form of the disease has also become more common than previously reported, accounting for 5–15% of NMTC ...
Tina Kamani +3 more
doaj +2 more sources
Combination of medullary thyroid cancer and renal cell carcinoma in one patient
Клиническая и экспериментальная тиреоидология, 2018 Patients who received treatment for the first malignant neoplasm remain in the group at increased risk of developing a second primary tumor throughout their later life.
Yuliya A. Dolinskaya +4 more
doaj +2 more sources
A Benign Medullary Thyroid Cancer [PDF]
Cureus, 2022 Metastatic dissemination occurs in up to 90% of patients with medullary thyroid cancer (MTC) greater than 4 cm in diameter, and elevated calcitonin levels of more than 500 pg/ml preoperatively have been shown to predict the failure to achieve biochemical remission. Herein, we present a patient with a large tumor and extremely elevated calcitonin level,
Pishdad, Reza +2 more
openaire +2 more sources
Emerging role of multikinase inhibitors for refractory thyroid cancer
Biologics: Targets & Therapy, 2012 Cesar A Perez,1 Belisario A Arango,1 Michel Velez,1 Luis E Raez,2 Edgardo S Santos11University of Miami Miller School of Medicine/Sylvester Comprehensive Cancer Center, Miami, USA; 2Memorial Cancer Institute, Memorial Health Care System, Hollywood, FL ...
Perez CA +4 more
doaj +1 more source
Medullary thyroid cancer in combination with autoimmune thyroiditis after COVID-19
Сибирский онкологический журнал, 2022 Background. Coronavirus disease 2019 (COVID-19) is a pandemic of the new millennium. COVID-19 can cause both pulmonary and systemic infammation, and can rapidly progress to multiple organ failure. Data on the relationship between COVID-19 and the thyroid
E. V. Ryabchenko
doaj +1 more source
Current Oncology, 2022 Selpercatinib, a RET kinase inhibitor, is an effective treatment for patients with medullary thyroid cancer with RET mutations. In this paper, we present the case of a 62-year-old man with ectopic Cushing’s syndrome due to medullary thyroid cancer who ...
Oskar Ragnarsson +2 more
doaj +1 more source
Diagnosis of medullary thyroid cancer [PDF]
F1000 Medicine Reports, 2009 Medullary thyroid cancer (MTC) accounts for 5-10% of all thyroid cancers. The majority of medullary thyroid cancers are sporadic, but 25% of cases are inherited as a result of germline mutations in the RET proto-oncogene. In sporadic cases MTC presents as a thyroid nodule discovered at palpation or at thyroid ultrasonography, and is indistinguishable ...
Marchisotta, Stefania, Pacini, Furio
openaire +2 more sources
Frontiers in Endocrinology, 2021 BackgroundSevere acute respiratory syndrome coronavirus-2 (SARS-CoV-2) is a novel coronavirus that has caused a worldwide pandemic. The majority of medullary thyroid cancers present as a thyroid nodule.
Livia Sira +7 more
doaj +1 more source